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Introduction 
 
The control of metabolic homeostasis is central to maintaining the physiological function 
and health of an organism.   A key player in the maintenance of cellular homeostasis are the 
semi-autonomous mitochondria, which produce ~95% of cellular ATP through the coupling 
of the electron transport chain (ETC) to oxidative phosphorylation (OXPHOS), by a proton 
electrochemical gradient across the mitochondrial inner membrane.  Mitochondria also 
provide the environment for other metabolic pathways such as the Kreb’s cycle, β-oxidation, 
the urea cycle, and they also regulate Ca2+ homeostasis and play a key role in cellular 
apoptosis. Metabolic homeostasis is coordinated by a combination of key transcription 
factors and post-transcriptional regulatory mechanisms, including non-coding RNAs that 
combine to form intricate regulatory control networks.   However, much remains to be 
understood about the role post-transcriptional processes play in the maintenance and 
regulation of the ETC and how they provide a further insight to the complexities underlying 
metabolic homeostasis.     
 
Post-transcriptional gene regulation (PTGR) can broadly be defined as the control of gene 
expression at the level of RNA transcript abundance, and includes aspects of RNA biology 
such as transcript stability/RNA turnover, binding of the RNAs by RNA binding proteins and 
post-transcriptional regulation by microRNAs (miRNAs). It is known that ETC transcripts 
range from being moderately to highly expressed and are relatively stable  [1] but little is 
known regarding the role of regulatory RNAs or RNA binding proteins in the PTGR of the ETC.  
This review aims to provide an overview of the current evidence for post-transcriptional 
regulation of the mitochondrial ETC and to discuss the role PTGR may play in diseases that 
exhibit mitochondrial dysfunction.   
 
The chemiosmotic coupling of the ETC to OXPHOS requires the activities of four multi-
subunit enzyme complexes (Complex I [CI], NADH-ubiquinone oxidoreductase; Complex II 
[CII], Succinate-quinone oxidoreductase; Complex III [CIII], Cytochrome bc1 complex; 
Complex IV [CIV], Cytochrome c oxidase), and ATP synthase (Complex V [CV]) as the site of 
OXPHOS, numerous assembly proteins and two electron carriers (ubiquinone and 
cytochrome c). Together the complexes and electron carriers comprise the ETC that 
transfers electrons from NADH (at complex I) and FADH2 (at complex II) through a series of 
redox reactions to molecular oxygen as a final electron acceptor (at complex IV). In doing so, 
protons are pumped across the inner mitochondrial membrane to create a proton 
electrochemical gradient that is required for ATP-synthase to phosphorylate ADP to produce 
ATP (oxidative phosphorylation) therefore providing energy for cellular processes.  In 
mammals the five enzyme complexes are comprised of approximately 100 separate protein 
subunits and are unique in the sense that their protein components are sourced from two 
separate genomes – the mitochondrial genome and the nuclear genome – which 
necessitates the coordinated (post)-transcriptional regulation of genes from both genomes.  
Because the mitochondrial genome only codes for 13 of these protein subunits (7 CI, 1 CIII, 3 
CIV and 2 CV) the majority of ETC subunit transcripts are encoded by the nuclear genome, 
translated in the cytoplasm and their proteins imported into the mitochondria.  The efficient 
function of the ETC therefore requires complex layers of regulation to coordinate the 
expression of the protein-coding subunits, including a combination of transcriptional co-
ordination, sub-cytoplasmic localization of translation and the intricate assembly of the ETC 
enzyme complexes.   
 
Post-transcriptional regulation of the ETC via miRNAs 
miRNAs are small (21-23 nucleotide) non-coding RNAs that post-transcriptionally regulate 
target genes in the cytoplasm through the activity of the multi-component RNA-induced 
silencing complex (RISC).  This occurs by the miRNA binding via a seed region in the mature 
miRNA, to a miRNA recognition element in a target sequence, with canonical binding being 
mostly targeted to the 3’ UTR.  This interaction of the miRNA with its target RNA is 
recognized by the Argonaute 2 (Ago2) component of RISC and either suppresses protein 
production and/or initiates mRNA degradation [2].  
 
miRNAs can confer robustness to gene expression networks is by suppressing ‘noise’ (for a 
review and examples see [3-5]), and by establishing gene expression thresholds which can 
help maintain homeostasis.  At present, miRNAs are known to participate in the regulation 
of various metabolic pathways including insulin signaling, glucose homeostasis, and lipid 
homeostasis [6-7].  Nevertheless, except for a few specific examples (discussed below) little 
is known about the magnitude of the role that miRNAs may play in the regulation of ETC 
transcripts (Figure 1A).  
 
A number of studies have reported interactions of miRNAs with ETC transcripts in different 
biological contexts. The brain-specific miRNA miR-338 has been shown to locally regulate 
cytochrome c oxidase IV (COX4, a complex IV subunit) transcript abundance in the axons of 
sympathetic neurons [8], thereby regulating axonal respiration.  A subsequent study 
identified the transcript ATP5G1 as an additional target of miR-338 in axons [9], suggesting 
that miR-338 may be coordinately regulating the availability of multiple ETC subunit 
transcripts in this system. 
 
The miRNA miR-210, which is induced under hypoxic conditions, has been demonstrated to 
act as part of a metabolic switch in the hypoxic response [10].  In human pulmonary artery 
cell lines miR-210 was initially shown to target transcripts encoding the iron-sulphur cluster 
assembly enzymes ISCU1/2 [10], which is a mitochondrially localized scaffold protein 
required for the maturation of [2Fe-2S] and [4Fe-4S] proteins [11].  By targeting ISCU1/2 the 
induction of miR-210 decreases the activity of Fe-S containing enzymes such as the Krebs 
cycle enzyme aconitase [10] and mitochondrial complex I [10, 12].  The complex II subunit 
SDHD has also been validated as a miR-210 target [13-15], as has the complex IV assembly 
factor COX10 [12] and NDUFA4 [14-16], which has recently been reassigned to complex IV 
[17]. These multiple miR-210 targets allow the coordinate regulation of mitochondrial 
respiration in response to hypoxia firstly by regulating the enzyme ISCU which has 
downstream effects on the Fe-S containing proteins of both the Kreb’s cycle and the 
electron transport chain and, secondly by directly targeting ETC subunit transcripts and 
assembly factors to further decrease ETC activity.  In addition, in human placentas 
presenting with preeclampsia a 2-fold increase of miR-210 is associated with decreased 
amounts of translated complexes I and IV and a decrease in the activity of complex III [18], 
implying an even broader role of miR-210 in the regulation of the ETC.  These various targets 
of miR-210 are suggestive of a hypoxia-induced post-transcriptional regulatory network 
which acts to co-ordinately down regulate key ETC enzymes involved in the hypoxic 
response.   
 
There is evidence of overlapping regulatory functions between miRNAs that share target 
genes.  miR-210 and miR-147b are induced by hypoxia and in inflammation respectively, and 
promote comparable cellular effects in terms of cell migration, proliferation and apoptosis 
[15]. These miRNAs share a minimal 6 base seed region and both directly interact with SDHD 
and NDUFA4 transcripts.  This miRNA functional redundancy, where different external 
stimuli can trigger the expression of different miRNAs acts as a ‘switch’ which leads to a 
common stress-related response characterised by overlapping miRNA target genes [15].   
 
Intriguingly, both pre and mature miRNAs (termed mitomiRs) have been found localized to 
the mitochondria, and miRNAs have been found to be present in the mitochondria isolated 
from rat liver [19], mouse liver [20], 143-B cells [21], myoblasts [22], HeLa cells [23] and 
HEK293 cells [23].  There is little consensus, however, regarding the functionality of these 
miRNAs within the mitochondria, and it is important to note that only one of these studies 
[22] used hybridization techniques to demonstrate miRNA localization to the mitochondria 
therefore artefacts due to the fractionation techiques utilized cannot be precluded.  The 
mitochondria have been proposed to act as a miRNA reservoir owing to some mitomiRs 
being predicted not to target the mitochondrial genome or nuclear encoded mitochondrial 
protein transcripts, but instead, transcripts encoding proteins involved in apoptosis, and cell 
proliferation and differentiation [19].  It is important to note that as of yet the targets of 
mitomiRs have not yet been extensively validated experimentally.  Nevertheless, one 
miRNA, miR-181c has been shown to be functional in the mitochondria of rat cardiac 
myocytes where it localizes within the mitochondria and translationally regulates mt-COX1 
[24].  In addition, as there is evidence that Agonaute proteins localize to the mitochondria 
[24-25] suggesting that the proteins required for miRNA mediated gene silencing may be 
present within the mitochondria.    Furthermore, there is some evidence that the 
mitochondrial genome itself generates non-coding RNAs [21, 26], although specific 
mitochondrial targets remain to be validated experimentally.  A deep sequencing approach 
identified small RNAs generated from either the mouse or the human mitochondrial genome 
ranging in size from 12 – 137 nucleotides [27].  In contrast to miRNA mediated repression, 
these mitochondrial genome-encoded small RNAs (mitosRNAs) appear to enhance the 
expression of their mitochondrial host genes [27].  It remains to be determined how 
extensive is the mitosRNA-regulation of mitochondrial gene expression, but it could 
represent a further component of PTGR.   
It should be noted that the miRNA pool do not bind just mRNAs, but potentially other non-
coding transcripts such as expressed pseudogenes, long non-coding RNAs (RNAs >200 
nucleotides in length with no coding capacity) and circular RNAs.  These transcripts can thus 
act as miRNA decoys, or competitive endogenous RNAs (ceRNAs), by binding miRNAs that 
would otherwise bind specific target mRNAs; these mRNAs are thus derepressed [28-30]. 
There is the potential for the miRNA-mediated regulation of ETC subunits to be buffered by 
a miRNA:mRNA:lncRNA network which maintains cellular homeostasis.   
 
Post-transcriptional regulation of the ETC via binding of ETC transcripts to RNA binding 
proteins 
Both nuclear and mitochondrially encoded ETC transcripts can also bind and be sequestered 
by RNA binding proteins (RBPs).  These are not only numerous and diverse, but they also 
have various cellular functions ranging from RNA modification in the nucleus (splicing, 
polyadenylation, 5’ capping), mRNA export, mRNA turnover, mRNA localisation and 
translation [31].    Recently, the FASTK family of  FAS-activated serine/threonine kinases 
have been identified as non-canonical RNA binding proteins implicated in mitochondrial 
physiology [32-34].  FASTKD4 (FAS-activated serine/threonine kinase D4) has been shown to 
mediate the turnover of a subset of mitochondrially encoded transcripts [35], whilst 
FASTKD2 (FAS-activated serine/threonine kinase D2), acts as an RNA binding protein that 
interacts with the mitochondrially encoded transcripts 16S ribosomal RNA (RNR2) and the 
complex I subunit ND6 [36].  Deletion of FASTKD2 results in aberrant processing and 
expression of both RNR2 and ND6 with a subsequent decrease in activity of all respiratory 
complexes, with the exception of complex II [36] (Figure 1B).  FASTKD2-mediated post-
transcriptional regulation of these genes is a critical cellular process because homozygous 
nonsense mutations in the FASTKD2 gene are associated with mitochondrial 
encephalomyopathy [33].   
 
Other RNA binding proteins have been shown to promote the expression of ETC subunits.  In 
HeLa cells, it has been demonstrated that YB-1 (Y-box-binding protein-1) regulates the 
translation of a subset of nuclear encoded ETC subunits by recruiting mRNAs from inactive 
ribonucleoprotein particles to active polysomes [37]. The ability of YB-1 to act as a 
translational activator depends on the amount of YB-1 bound to the target mRNA.   For 
example, after siRNA mediated YB-1 depletion the protein expression levels of complex I 
(NDUFA9, NDUFA8), complex II (SDHB) and complex III (UQCRFS1) subunits were increased 
by approximately 50%, with a concomitant increase in respiratory chain activity [37] (Figure 
1C) suggesting that YB-1 is an important mediating factor for modulating the translation of 
ETC subunits.   
 
In mice, the RNA binding protein Lin28a is a repressor of let-7 miRNA biogenesis, but it also 
regulates mRNA translation independently [38].  In mouse embryonic fibroblasts and mouse 
pinnae LIN28a binds to, and enhances the translation of, transcripts encoding the complex I 
subunits Ndufb3 and Ndufb8, and the complex II subunit Sdha, in addition to glycolytic and 
Krebs cycle transcripts [39].  This Lin28a mediated translational upregulation results in an 
increase in mitochondrial respiration, and is part of the Lin28-mediated reprogramming of 
metabolism that enhances tissue repair [39] (Figure 1D). 
 
Although the homeobox proteins are well known as transcription factors, some also function 
as translational regulators by interacting with the eukaryotic translation initiation factor 
eIF4E [40]. Exogenous application of the homeobox protein engrailed-1 (En-1) enhances the 
translation of the core mitochondrial subunits Ndufs1 and Ndufs3, which leads to a 20% 
increase in the activity of complex I (Figure 1E).  In turn, this protects mouse midbrain 
dopaminergic neurons against the complex I inhibitor used to model Parkinson’s disease, 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [41]. It also doubles striatal dopamine 
concentrations, an  effect that is dependent upon the translation of Ndufs1 [41].   
 
Together, this experimental evidence suggests that miRNAs and RNA binding proteins post-
transcriptionally regulate nuclear-encoded mitochondrial subunits and contribute centrally 
to the regulation and homeostatic control of energy metabolism.  
 
High-throughput detection of miRNAs and ETC targets 
Genome scale technologies have recently been implemented to identify differentially 
expressed miRNAs and/or miRNA targets.  miRNA microarrays were to identify miRNAs that 
are differentially regulated during mouse aging in combination with global proteomic 
profiling strategy to identify differentially expressed proteins [42]. This strategy identified 27 
miRNAs that were upregulated with a concomitant decrease in the expression of 10 ETC 
proteins (complex III: UQCR2, UQCRB, UQCRFS1; complex IV: COX5A, COX5B, COX7A2; ATP 
synthase: ATP5B, ATP5F1, ATP5H, ATP5O) in ageing mice.   A similar approach using miRNA 
and mRNA microarrays was taken to identify differentially expressed miRNAs and target 
genes in neural precursors derived from human umbilical cord mesenchymal stem cells [43].  
This study identified miR-34a as a miRNA involved in neurogenesis, and demonstrated that 
expression of miR-34a expression results in the downregulation of at least eight ETC 
subunits (Complex I: Ndufa3, Ndufb2, Ndufb7, NdufS6; Complex III: UQCR; Complex IV: 
Ndufa4; Complex V: ATP5F1, ATP5G3).  
 
Many studies are now combining high throughput sequencing with different approaches 
that investigate RNA interactions with proteins, specifically Argonaute proteins (e.g. HITS-
CLIP, PAR-CLIP, CLASH), to identify miRNA-target interactions (for a review of RNA-protein 
interaction technology see [44]).   These studies are investigating miRNA:target interactions 
at a transcriptome-wide scale and therefore provide an excellent resource of potential 
miRNA:mRNA interactions that can be mined to identify targets for further investigation.  
Table 1 illustrates examples of datasets where potentially novel ETC:miRNA interactions 
have been identified.  
 
These high-throughput techniques provide a broad transcriptome-wide overview of 
potential miRNA:target interactions.  Nevertheless, confidence in the validity of the 
proposed interactions requires subsequent experimental validation. 
 
Does PTGR of the ETC play a central role in mitochondrial dysfunction? 
Whilst much is understood about the biochemical mechanisms underlying oxidative 
phosphorylation, in situations of mitochondrial dysfunction, where mitochondria fail to 
generate appropriate amounts of ATP in response to energy demands, little is known about 
the underlying causes.  Mitochondrial dysfunction is an important pathophysiological 
feature of many apparently disparate diseases including neurodegenerative disorders such 
as Parkinson’s and Alzheimer’s diseases [45-47], mental health disorders [48-49], type II 
diabetes [50] and heart disease [51].  Inherited mutations in protein coding genes are often 
not sufficient to explain the prevalence of sporadic cases of these diseases, and increased 
susceptibility to complex neurodegenerative and neuropsychological disorders are likely to 
be the product of multiple mutations. Given the etiological complexity of these diseases, it is 
possible that mutations in PTGR networks regulating the ETC may contribute to the 
observed pathologies.  
 
Concluding statement 
The extent to which PTGR influences the activity of the ETC has yet to be fully elucidated. 
However, there is clear experimental evidence that both miRNAs and RNA binding proteins 
have the potential to play significant post-transcriptional regulatory roles in different 
disease contexts.  If we add to this post-transcriptional network other non-coding RNAs, 
such as the ceRNAs, we begin to envisage a complex post-transcriptional network that can 
respond rapidly to stimuli to preserve homeostasis. Importantly, a better understanding of 
these networks could help to determine what roles they may play in diseases that manifest 
defects in energy metabolism and could help identify much needed new drug targets for 
treating mitochondrial dysfunction. 
 
 
 
 
Species/Cell line 
 
 
Technique 
Number of 
miRNA:ETC 
transcript 
interactions 
Non-redundant 
Number of ETC 
transcripts 
identified 
Non-redundant 
Number of 
miRNAs 
Human HEK293 
cells [52] 
CLASH 295 74 104 
Human 293S and 
HeLa cells [53] 
HITS-CLIP 422 27 307 
Human HIV-1 
infected C8166 T 
cells or TZM-bl 
epithelial cells 
[54] 
PAR-CLIP 249 14 231 
Human HEK 293 
cells [55] 
PAR-CLIP 229 18 210 
Table 1.  Example of potentially novel miRNA interactions with ETC transcripts identified 
from high throughput screening datasets of RNA:protein interactions.  Datasets were 
downloaded from miRTarBase [56]. 
 
  
Figure legend 
Figure 1.  Summary of the post-transcriptional gene regulation mechanisms known to 
regulate ETC transcript abundance.  A) Schematic representation of the ETC complexes 
indicating which transcripts have known miRNA mediated regulation that has a downstream 
biochemical effect.  B) Down-regulation of the RNA binding protein FASTKD2 results in a 
decrease in activity of all mitochondrial complexes that contain mitochondrially encoded 
subunits C) Down-regulation of the RNA binding protein YB-1 results in release of ETC 
transcripts from RNPs and subsequent recruitment to the polysomes for translation, leading 
to increases in catalytic activity of all complexes. D) Lin28A binds to and enhances the 
translation of some ETC transcripts leading to an overall increase in mitochondrial 
respiration. E) The homeobox transcription factor En-1, through an interaction with the 
eukaryotic translation initiation factor eIF4E, specifically enhances the translation of two 
mitochondrial complex I transcripts, leading to an increase in complex I enzymatic activity.   
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